Introduction
Materials and methods
Type of study
Type of participants
Type of outcome measures
Search strategy
Study selection and data extraction
Statistical analysis
Results
Study characteristics
Quality of the studies
Colonization with S. aureus of skin and mucosae in psoriasis
Author | Patients | Controls | Odds ratio (95 % CI) | ||||
---|---|---|---|---|---|---|---|
Sample size | Event rate colonization lesional skin (95 % CI) | Event rate colonization non-lesional skin (95 % CI) | Sample size | Event rate colonization skin (95 % CI) | |||
Atefi et al. 2012 [19] | 40 | 0.08 (0.02–0.21) | 40 | 0.03 (0.00–0.16) | 3.16 (0.32–31.78) | ||
Tabatabaei et al. 2011 [48] | 50 | 0.06 (0.02–0.17) | 50 | 0.02 (0.00–0.13) | 3.13 (0.31–31.14) | ||
Balci et al. 2009 [13] | 50 | 0.64 (0.50–0.76) | 0.14 (0.07–0.27) | ||||
Tomi et al. 2005 [49] | 25 | 0.44 (0.26–0.63) | 25 | 0.04 (0.01–0.24) | 18.86 (2.20–161.99) | ||
Ryu et al. 2003 [50] | 22 | 0.45 (0.26–0.65) | 0.33 (0.17–0.55)a
| 25 | 0.32 (0.17–0.52) | Lesional skin 1.74 (0.53–5.70) Non-lesional 1.04 (0.31–3.56) | |
Brook et al. 1999 [51] | 28 | 0.54 (0.35–0.71) | |||||
Sayama et al. 1998 [52] | 100 | 0.15 (0.09–0.23) | 0.06 (0.02–0.13)b
| ||||
Noah et al. 1990 [53] | Overall c
| 297 | 0.03 (0.02–0.06) | ||||
Axilla | 297 | 0.01 (0.00–0.03) | |||||
Submammary | 297 | 0.01 (0.00–0.03) | |||||
Umbilical | 297 | 0.02 (0.01–0.05) | |||||
Inguinal | 297 | 0.02 (0.01–0.05) | |||||
Gluteal | 297 | 0.10 (0.07–0.14) | |||||
Vaginal | 297 | 0.03 (0.01–0.05) | |||||
Penis-scrotal | 297 | 0.04 (0.02–0.07) | |||||
Weissmann et al. 1980 [54] | Overall d
| 10 | 0.55 (0.42–0.67) | ||||
Arm before treatment | 10 | 0.50 (0.22–0.78) | |||||
Back before treatment | 10 | 0.60 (0.30–0.84) | |||||
Arm after treatment | 10 | 0.40 (0.16–0.70) | |||||
Back after treatment | 9 | 0.33 (0.11–0.66) | |||||
Aly et al. 1976 [55] | 40 | 0.20 (0.10–0.35) | 0.13 (0.05–0.27) |
Author | Patients | Controls | Odds ratio (95 % CI) | ||
---|---|---|---|---|---|
Sample size | Event rate of nasal colonization (95 % CI) | Sample size | Event rate of nasal colonization (95 % CI) | ||
Andersen et al. 2013 [56] | 112 | 0.36 (0.28–0.45) | 1985 | Not mentioned | 1.73 (1.16–2.58) |
Balci et al. 2009 [13] | 50 | 0.50 (0.36–0.64) | 50 | 0.34 (0.22–0.48) | 1.94 (0.87–4.35) |
Tomi et al. 2005 [49] | 25 | 0.56 (0.37–0.74) | 25 | 0.08 (0.02–0.27) | 14.64 (2.82–75.95) |
Ryu et al. 2003 [50] | 22 | 0.27 (0.13–0.49) | 25 | 0.24 (0.11–0.44) | 1.18 (0.32–4.40) |
Klein et al. 1997 [57] | 33 | 0.33 (0.19–0.51) | |||
Singh et al. 1978 [58] | 50 | 0.76 (0.62–0.86) | 33 | 0.6 (0.43–0.75) | 2.64 (1.03–6.79) |
Aly et al. 1976 [55] | 40 | 0.30 (0.18–0.46) |
Colonization with S. aureus of skin and mucosae in acne
Author | Patients | Controls | Odds ratio (95 % CI) | ||||
---|---|---|---|---|---|---|---|
Sample size | Event rate of lesional skin colonization (95 % CI) | Event rate of non-lesional skin colonization (95 % CI) | Sample size | Event rate skin colonization (95 % CI) | |||
Numata et al. 2013 [60] | 100 | 0.01 (0.00–0.07)a
| 100 | 0.01 (0.00–0.07)a
| |||
Moon et al. 2012 [61] | 100 | 0.06 (0.03–0.13) | |||||
Hassanzadeh et al. 2008 [62] | 100 | 0.41 (0.32–0.51) | 100 | 0.30 (0.22–0.40)b
| 1.62 (0.90–2.91) | ||
Williams et al. 1992c [63] | Before treatment | 28 | 0.02 (0.00–0.22)a
| ||||
1 month after start | 28 | 0.14 (0.05–0.32) | |||||
2 months after start | 28 | 0.32 (0.18–0.51) | |||||
3 months after start | 28 | 0.21 (0.10–0.40) | |||||
4 months after start | 28 | 0.25 (0.12–0.44) | |||||
5 months after start | 28 | 0.02 (0.00–0.22)a
| |||||
Al Mishari et al. 1987d [35] | Before treatment | 20 | 0.05 (0.01–0.28) | 0.05 (0.01–0.28) | |||
4 months after start | 20 | 0.02 (0.00–0.29)a
| |||||
Leyden et al. 1986e [64] | Before treatment | 40 | 0.03 (0.00–0.16) | ||||
1 month after start | 40 | 0.15 (0.07–0.30) | |||||
5 months after start | 40 | 0.50 (0.35–0.65) | |||||
Batova et al. 1971 [65] | Swab without buffer | 40 | 0.15 (0.07–0.30) | ||||
Swab with buffer | 50 | 0.54 (0.40–0.67) | 50 | 0.22 (0.13–0.36) | 4.16 (1.74–9.94) |
Author | Patients | Controls | Odds ratio | |||
---|---|---|---|---|---|---|
Sample size | Event rate of nasal colonization (95 % CI) | Sample size | Event rate of nasal colonization (95 % CI) | |||
Ozuguz et al. 2014a [66] | Before treatment | 55 | 0.01 (0.00–0.13)e
| 20 | 0.02 (0.01–0.29)e
| |
3 months after start | 55 | 0.09 (0.04–0.20) | ||||
Basak et al. 2013b [67] | Before treatment | 35 | 0.09 (0.03–0.23) | |||
After treatment | 35 | 0.40 (0.25–0.57) | ||||
Toyne et al. 2012 [68] | 116 | 0.26 (0.19–0.35) | ||||
Khorvash et al. 2012 [69] | 166 | 0.22 (0.16–0.29) | 158 | 0.27 (0.20–0.34) | 0.77 (0.46–1.29) | |
Fanelli et al. 2011 [70] | 83 | 0.19 (0.12–0.29) | ||||
Williams et al. 1992c [63] | Before treatment | 28 | 0.11 (0.03–0.28) | |||
1 month after start | 28 | 0.32 (0.18–0.51) | ||||
2 months after start | 28 | 0.57 (0.39–0.74) | ||||
3 months after start | 28 | 0.46 (0.29–0.64) | ||||
4 months after start | 28 | 0.32 (0.18–0.51) | ||||
5 months after start | 28 | 0.43 (0.26–0.61) | ||||
Leyden et al. 1986d [64] | Before treatment | 40 | 0.03 (0.00–0.16) | |||
1 months after start | 40 | 0.30 (0.18–0.46) | ||||
5 months after start | 40 | 0.70 (0.54–0.82) |